Structures by: Ponnuswamy S.
Total: 51
N-Methyl-2,4-diphenyl-7-tertiary butyl 3-azabicyclo[3.3.1]nonane
C25H33N
Acta Crystallographica Section B (1999) 55, 5 793-798
a=13.6670(10)Å b=16.414(2)Å c=9.4090(10)Å
α=90.00° β=94.540(10)° γ=90.00°
N-Acetyl-2,4-diphenyl-3-azabicyclo[3.3.1]nonane
C22H25NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=14.6870(10)Å b=12.9310(10)Å c=18.5640(10)Å
α=90.00° β=90.00° γ=90.00°
N-Methyl-2,4-diorthomethyl phenyl-9-hydroxy 3-azabicyclo[3.3.1]nonane
C23H29NO
Acta Crystallographica Section B (1999) 55, 5 793-798
a=7.6380(10)Å b=13.1880(10)Å c=18.865(2)Å
α=90.00° β=97.940(10)° γ=90.00°
<i>N</i>-acetyl-3-isopropyl-2,6-diphenylpiperidine
C22H27NO
Acta Crystallographica Section E (2020) 76, 3 377-381
a=13.3077(5)Å b=10.3009(4)Å c=13.9338(5)Å
α=90° β=104.6570(10)° γ=90°
2-Chloro-1-(3-ethyl-2,6-diphenylpiperidin-1-yl)ethanone
C21H24ClNO
Acta Crystallographica Section E (2015) 71, 2 o122
a=8.5971(9)Å b=12.9080(13)Å c=17.1114(16)Å
α=90.00° β=100.501(5)° γ=90.00°
2,2,4-Trimethyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>][1,4]diazepine hemihydrate
C12H18N2,0.5(H2O)
Acta Crystallographica Section E (2015) 71, 8 o570-o571
a=9.0548(10)Å b=23.246(2)Å c=11.5613(14)Å
α=90° β=100.483(3)° γ=90°
1-[2,4-Bis(4-methoxyphenyl)-3-azabicyclo[3.3.1]nonan-3-yl]ethanone
C24H29NO3
Acta Crystallographica Section E (2014) 70, 11 o1171-o1172
a=7.6309(13)Å b=17.102(3)Å c=15.395(2)Å
α=90.00° β=93.886(5)° γ=90.00°
N-ethoxycarbonyl-3,5-dimethyl-cis-2,6-diphenyl piperidin-4-one
C22H25NO3
Acta Crystallographica Section C (1998) 54, 6 870-872
a=10.404(2)Å b=9.743(2)Å c=19.096(3)Å
α=90.00° β=95.70(2)° γ=90.00°
1-Acetyl-2,6-bis(4-methoxyphenyl)-3-methyl-4-piperidone
C22H25NO4
Acta Crystallographica Section E (2007) 63, 8 o3648
a=17.2799(5)Å b=10.6783(3)Å c=10.5702(3)Å
α=90.00° β=90.9510(10)° γ=90.00°
Benzodiazepine
C19H23N3O
Acta Crystallographica Section E (2007) 63, 11 o4264-o4264
a=6.60100(10)Å b=13.8353(2)Å c=37.7572(6)Å
α=90° β=90° γ=90°
3-Ethyl-2,6-bis(4-methoxyphenyl)piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2007) 63, 10 o3985-o3985
a=14.012(2)Å b=7.8060(14)Å c=17.655(3)Å
α=90.00° β=110.401(5)° γ=90.00°
1-Chloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H22ClNO2
Acta Crystallographica Section E (2008) 64, 10 o2041
a=13.7005(3)Å b=9.8735(2)Å c=14.8960(3)Å
α=90.00° β=112.7620(10)° γ=90.00°
2-Chloro-1-(3-methyl-2,6-diphenylpiperidin-1-yl)ethanone
C20H22ClNO
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o135
a=8.7146(3)Å b=12.3963(4)Å c=16.6117(6)Å
α=90.00° β=101.523(2)° γ=90.00°
R-2,c-6-Bis(4-methoxyphenyl)-c-3,t-3-dimethyl-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 6 o1420
a=7.2540(3)Å b=15.0469(6)Å c=17.0741(7)Å
α=90.00° β=90.00° γ=90.00°
Piperidin-4-one
C19H19Cl2NO
Acta Crystallographica Section E (2008) 64, 12 o2312
a=13.1627(5)Å b=22.4739(7)Å c=5.8794(2)Å
α=90° β=90° γ=90°
5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C12H13ClN2O2
Acta Crystallographica Section E (2009) 65, 10 o2361
a=16.7656(4)Å b=8.8171(2)Å c=17.0125(4)Å
α=90.00° β=105.8030(10)° γ=90.00°
4-Methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine-5-carbaldehyde
C11H12N2O2
Acta Crystallographica Section E (2009) 65, 10 o2362
a=5.32840(10)Å b=12.9387(4)Å c=14.6227(5)Å
α=90.00° β=97.968(2)° γ=90.00°
N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate
2(C12H12Cl2N2O2),H2O
Acta Crystallographica Section E (2009) 65, 10 o2551-o2552
a=8.5470(3)Å b=18.0837(6)Å c=8.8697(3)Å
α=90.00° β=95.405(2)° γ=90.00°
2,2,4-Trimethyl-5-(4-tolylsulfonyl)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine
C19H24N2O2S
Acta Crystallographica Section E (2009) 65, 10 o2363-o2364
a=7.3658(3)Å b=14.8013(8)Å c=17.4556(10)Å
α=90.00° β=90.00° γ=90.00°
1-Formyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 4 o856
a=11.7274(3)Å b=18.8556(4)Å c=9.7178(3)Å
α=90.00° β=113.5070(10)° γ=90.00°
1-Dichloroacetyl-3,3-dimethyl-2,6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2009) 65, 1 o10
a=9.1084(2)Å b=10.8992(3)Å c=10.9918(3)Å
α=63.8790(10)° β=85.343(2)° γ=79.0290(10)°
1-Dichloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one
C23H25Cl2NO4
Acta Crystallographica Section E (2009) 65, 1 o11
a=23.6295(9)Å b=10.3999(4)Å c=19.2617(9)Å
α=90.00° β=107.7340(10)° γ=90.00°
T-3-Ethyl-r-2,c-6-bis(4-methoxyphenyl)-1-nitrosopiperidin-4-one
C21H24N2O4
Acta Crystallographica Section E (2009) 65, 8 o1765
a=7.2742(4)Å b=15.8459(7)Å c=16.4800(7)Å
α=90.00° β=90.00° γ=90.00°
1-Formyl-<i>t</i>-3,<i>t</i>-5-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2010) 66, 6 o1505
a=7.4303(4)Å b=15.3567(6)Å c=29.6732(13)Å
α=90.00° β=90.00° γ=90.00°
Piperidin-4-one
C21H25NO
Acta Crystallographica Section E (2009) 65, 10 o2445
a=12.9576(3)Å b=22.6153(5)Å c=5.96000(10)Å
α=90° β=90° γ=90°
Piperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2008) 64, 12 o2328
a=5.9772(2)Å b=23.0858(8)Å c=26.7611(8)Å
α=90° β=93.543(3)° γ=90°
1-Acetyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C21H23NO2
Acta Crystallographica Section E (2009) 65, 8 o1974
a=7.5622(4)Å b=10.6369(5)Å c=11.1497(7)Å
α=90.00° β=100.373(3)° γ=90.00°
1-Benzoyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C26H25NO2
Acta Crystallographica Section E (2009) 65, 8 o1975
a=10.8540(9)Å b=17.8050(17)Å c=10.8853(10)Å
α=90.00° β=94.987(3)° γ=90.00°
<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C19H21NO
Acta Crystallographica Section E (2009) 65, 11 o2794
a=6.0293(4)Å b=10.8198(6)Å c=12.1649(6)Å
α=98.559(2)° β=92.836(3)° γ=96.677(3)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-4-oxo-<i>r</i>-2,<i>c</i>-6-diphenylpiperidine-1-carboxamide
C26H26N2O2
Acta Crystallographica Section E (2009) 65, 11 o2808
a=9.6648(2)Å b=10.7938(3)Å c=11.4233(3)Å
α=101.303(2)° β=90.1580(10)° γ=113.1910(10)°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H24ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2883
a=8.9147(8)Å b=11.9648(10)Å c=19.1365(16)Å
α=99.729(5)° β=93.665(5)° γ=90.112(6)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-7-diphenyl-1,4-diazepan-5-one
C19H22N2O
Acta Crystallographica Section E (2009) 65, 11 o2884
a=6.7354(4)Å b=10.6867(6)Å c=11.4186(7)Å
α=82.191(3)° β=88.218(4)° γ=80.317(3)°
1-Formyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)- <i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 11 o2818
a=11.0954(4)Å b=14.5407(3)Å c=12.7050(4)Å
α=90.00° β=110.9770(10)° γ=90.00°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>c</i>-3,<i>t</i>-3-dimethylpiperidin-4-one
C23H26ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2793
a=12.5928(4)Å b=9.4141(3)Å c=17.9070(6)Å
α=90.00° β=90.8260(10)° γ=90.00°
<i>t</i>-3-Ethyl-<i>r</i>-2,<i>c</i>-7-bis(4-methoxyphenyl)-1,4-diazepan-5-one
C21H26N2O3
Acta Crystallographica Section E (2009) 65, 11 o2885-o2886
a=10.5190(3)Å b=13.3480(4)Å c=15.0472(4)Å
α=102.118(2)° β=93.662(2)° γ=110.287(2)°
Piperidin-4-one
C21H23NO4
Acta Crystallographica Section E (2009) 65, 11 o2813
a=11.5409(4)Å b=12.4972(5)Å c=14.7816(6)Å
α=67.878(4)° β=74.719(3)° γ=67.123(4)°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C23H25Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o263
a=8.1251(7)Å b=9.9702(9)Å c=27.649(2)Å
α=90.00° β=92.265(5)° γ=90.00°
1-Chloroacetyl-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C22H24ClNO2
Acta Crystallographica Section E (2010) 66, 2 o276-o277
a=10.3415(12)Å b=9.0243(9)Å c=21.438(2)Å
α=90.00° β=90.894(3)° γ=90.00°
1-Acetyl-<i>t</i>-3-ethyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)piperidin-4-one
C23H27NO4
Acta Crystallographica Section E (2010) 66, 2 o275
a=8.6736(11)Å b=13.4578(16)Å c=17.547(2)Å
α=90.00° β=90.00° γ=90.00°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H23Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o262
a=19.3021(16)Å b=10.5886(9)Å c=10.3241(10)Å
α=90.00° β=91.445(5)° γ=90.00°
Cyclohexane-1-spiro-2'-imidazolidine-5'-spiro-1''-cyclohexan-4'-one
C13H22N2O
Acta Crystallographica Section E (2010) 66, 5 o1072
a=5.8270(8)Å b=10.1703(5)Å c=10.6651(4)Å
α=86.103(2)° β=81.331(3)° γ=89.720(3)°
2-Chloro-1-(2,4,4-trimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-1-yl)ethanone
C14H19ClN2O
Acta Crystallographica Section E (2013) 69, 6 o874
a=10.3971(3)Å b=12.2589(3)Å c=11.0994(3)Å
α=90.00° β=93.9530(10)° γ=90.00°
3-Ethyl-<i>cis</i>-2,6-diphenylpiperidine
C19H23N
Acta Crystallographica Section E (2013) 69, 9 o1441
a=5.5384(5)Å b=9.2717(9)Å c=16.0483(14)Å
α=75.508(5)° β=89.474(5)° γ=81.625(5)°
2-Chloro-1-(3,3-dimethyl-2,6-diphenylpiperidin-1-yl)ethanone
C21H24ClNO
Acta Crystallographica Section E (2013) 69, 9 o1424
a=7.5488(6)Å b=9.9706(7)Å c=12.9887(10)Å
α=106.783(4)° β=93.022(4)° γ=102.347(4)°
1-Formyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2012) 68, 3 o870
a=10.6604(6)Å b=15.7278(7)Å c=10.8066(5)Å
α=90.00° β=110.120(2)° γ=90.00°
3-Isopropyl-2,6-bis(4-methoxyphenyl)piperidin-4-one
C22H27NO3
Acta Crystallographica Section E (2012) 68, 8 o2453
a=7.5547(3)Å b=11.8792(6)Å c=22.1103(10)Å
α=90.00° β=90.00° γ=90.00°
N-Dichloroacetyl-t-3,t-5-dimethyl-r-2,c-6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2013) 69, 4 o609
a=8.278(2)Å b=9.714(3)Å c=11.847(3)Å
α=90.00° β=90.578(9)° γ=90.00°
<i>c</i>-3,<i>t</i>-5-Dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidine
C19H23N
Acta Crystallographica Section E (2014) 70, 4 o404
a=10.1689(8)Å b=43.141(3)Å c=7.2658(5)Å
α=90.00° β=90.00° γ=90.00°
1-Dichloroacetyl-<i>t</i>-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C22H23Cl2NO2
Acta Crystallographica Section E (2013) 69, 8 o1348
a=18.4336(14)Å b=9.4516(7)Å c=11.7077(9)Å
α=90.00° β=90.00° γ=90.00°
1-(2,2-Dichloroacetyl)-3-ethyl-2,6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2013) 69, 5 o800
a=17.4615(13)Å b=19.0291(15)Å c=11.9501(9)Å
α=90.00° β=91.825(5)° γ=90.00°
<i>r</i>-2,<i>c</i>-6-Diphenylpiperidine
C17H19N
Acta Crystallographica Section E (2013) 69, 9 o1371
a=5.6450(9)Å b=11.2255(17)Å c=11.5281(17)Å
α=73.911(9)° β=89.898(9)° γ=81.466(9)°